Association of ornithine transcarbamylase gene polymorphisms with hypertension and coronary artery vasomotion

American Journal of Hypertension

Volumn 22, Issue 9, 2009, Pages 993-1000

  Dumont, Julie ^a,b,c   Meroufel, Djabaria ^a,b,c,d   Bauters, Christophe ^a,b,c,e   Hansmannel, Franck ^a,b,c   Bensemain, Faza ^a,b,c   Cottel, Dominique ^a,b,c   Hamon, Martial ^a,b,c,f   Lambert, Jean Charles ^a,b,c   Ducimetière, Pierre ^a,g   Amouyel, Philippe ^a,b,c   Zureik, Mahmoud ^a,b,c   Brousseau, Thierry ^a,b,c  

^a INSERM   (France)

^b INSTITUT PASTEUR DE LILLE   (France)

^c UNIV LILLE   (France)

^d UNIVERSITÉ DES SCIENCES ET DE LA TECHNOLOGIE D ORAN MOHAMED BOUDIAF   (Algeria)

^e LILLE UNIVERSITY HOSPITAL   (France)

^f CAEN UNIVERSITY HOSPITAL   (France)

^g Paris Sud   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ISOSORBIDE DINITRATE; METHYLERGOMETRINE MALEATE; ORNITHINE CARBAMOYLTRANSFERASE;

ADULT; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; GENOTYPE; HAPLOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; UREA CYCLE; VASOCONSTRICTION; VASODILATATION; VASOMOTOR REFLEX; X CHROMOSOME;

ADULT; AGED; BLOOD PRESSURE; CORONARY VASOSPASM; CORONARY VESSELS; FEMALE; FRANCE; GENE FREQUENCY; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; ORNITHINE CARBAMOYLTRANSFERASE; POLYMORPHISM, SINGLE NUCLEOTIDE; SEX FACTORS; VASOCONSTRICTION; VASODILATION;

EID: 69249218907     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2009.110     Document Type: Article

References (30)

1. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell 2001; 104:545-556.
2. Tanira MO, Al Balushi KA. Genetic variations related to hypertension: a review. J Hum Hypertens 2005; 19:7-19.
3. Williams SM, Addy JH, Phillips JA, Dai M, Kpodonu J, Afful J, Jackson H, Joseph K, Eason F, Murray MM, Epperson P, Aduonum A, Wong LJ, Jose PA, Felder RA. Combinations of variations in multiple genes are associated with hypertension. Hypertension 2000; 36:2-6.
4. Guyton AC. Blood pressure control-special role of the kidneys and body fluids. Science 1991; 252:1813-1816.
5. Tsukaguchi H, Shayakul C, Berger UV, Hediger MA. Urea transporters in kidney: molecular analysis and contribution to the urinary concentrating process1. Am J Physiol 1998; 275:F319-F324.
6. Ranade K, Wu KD, Hwu CM, Ting CT, Pei D, Pesich R, Hebert J, Chen YD, Pratt R, Olshen R, Masaki K, Risch N, Cox DR, Botstein D. Genetic variation in the human urea transporter-2 is associated with variation in blood pressure. Hum Mol Genet 2001; 10:2157-2164.
7. Hong X, Xing H, Yu Y, Wen Y, Zhang Y, Zhang S, Tang G, Xu X. Genetic polymorphisms of the urea transporter gene are associated with antihypertensive response to nifedipine GITS. Methods Find Exp Clin Pharmacol 2007; 29:3-10.
8. Gewaltig MT, Kojda G. Vasoprotection by nitric oxide: mechanisms and therapeutic potential. Cardiovasc Res 2002; 55:250-260.
9. Hecker M, Sessa WC, Harris HJ, Anggård EE, Vane JR. The metabolism of l-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: cultured endothelial cells recycle L-citrulline to L-arginine. Proc Natl Acad Sci USA 1990; 87:8612-8616.
10. Morris SM. Regulation of enzymes of the urea cycle and arginine metabolism. Annu Rev Nutr 2002; 22:87-105.
11. Summar ML, Gainer JV, Pretorius M, Malave H, Harris S, Hall LD, Weisberg A, Vaughan DE, Christman BW, Brown NJ. Relationship between carbamoylphosphate synthetase genotype and systemic vascular function. Hypertension 2004; 43:186-191.
12. Zhang C, Hein TW, Wang W, Miller MW, Fossum TW, McDonald MM, Humphrey JD, Kuo L. Upregulation of vascular arginase in hypertension decreases nitric oxide-mediated dilation of coronary arterioles. Hypertension 2004; 44:935-943.
13. Johnson FK, Johnson RA, Peyton KJ, Durante W. Arginase inhibition restores arteriolar endothelial function in Dahl rats with salt-induced hypertension. Am J Physiol Regul Integr Comp Physiol 2005; 288:R1057-R1062.
14. Lighthall GK, Hamilton BP, Hamlyn JM. Identification of salt-sensitive genes in the kidneys of Dahl rats. J Hypertens 2004; 22:1487-1494.
15. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994; 90:583-612.
16. Zureik M, Ducimetière P, Touboul PJ, Courbon D, Bonithon-Kopp C, Berr C, Magne C. Common carotid intima-media thickness predicts occurrence of carotid atherosclerotic plaques: longitudinal results from the Aging Vascular Study (EVA) study. Arterioscler Thromb Vasc Biol 2000; 20:1622-1629.
17. Amant C, Hamon M, Bauters C, Richard F, Helbecque N, McFadden EP, Escudero X, Lablanche JM, Amouyel P, Bertrand ME. The angiotensin II type 1 receptor gene polymorphism is associated with coronary artery vasoconstriction. J Am Coll Cardiol 1997; 29:486-490.
18. Yamaguchi S, Brailey LL, Morizono H, Bale AE, Tuchman M. Mutations and polymorphisms in the human ornithine transcarbamylase (OTC) gene. Hum Mutat 2006; 27:626-632.
19. Tregouet DA, Escolano S, Tiret L, Mallet A, Golmard JL. A new algorithm for haplotype-based association analysis: the Stochastic-EM algorithm. Ann Hum Genet 2004; 68:165-177.
20. Bensemain F, Hot D, Ferreira S, Dumont J, Bombois S, Maurage CA, Huot L, Hermant X, Levillain E, Hubans C, Hansmannel F, Chapuis J, Hauw JJ, Schraen S, Lemoine Y, Buée L, Berr C, Mann D, Pasquier F, Amouyel P, Lambert JC. Evidence for induction of the ornithine transcarbamylase expression in Alzheimer's disease. Mol Psychiatry 2009; 14:106-116.
21. Brush JE, Cannon RO, Schenke WH, Bonow RO, Leon MB, Maron BJ, Epstein SE. Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med 1988; 319:1302-1307.
22. Millette E, de Champlain J, Lamontagne D. Altered coronary dilation in deoxycorticosterone acetate-salt hypertension. J Hypertens 2000; 18: 1783-1793.
23. Chen YF. Sexual dimorphism of hypertension. Curr Opin Nephrol Hypertens 1996; 5:181-185.
24. Tousoulis D, Kaski JC, Bogaty P, Crea F, Gavrielides S, Galassi AR, Maseri A. Reactivity of proximal and distal angiographically normal and stenotic coronary segments in chronic stable angina pectoris. Am J Cardiol 1991; 67:1195-1200.
25. Siffert W, Rosskopf D, Siffert G, Busch S, Moritz A, Erbel R, Sharma AM, Ritz E, Wichmann HE, Jakobs KH, Horsthemke B. Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet 1998; 18:45-48.
26. Meirhaeghe A, Bauters C, Helbecque N, Hamon M, McFadden E, Lablanche JM, Bertrand M, Amouyel P. The human G-protein β3 subunit C825T polymorphism is associated with coronary artery vasoconstriction. Eur Heart J 2001; 22:845-848.
27. Maseri A, Davies G, Hackett D, Kaski JC. Coronary artery spasm and vasoconstriction. The case for a distinction. Circulation 1990; 81:1983-1991.
28. Auch-Schwelk W, Paetsch I, Krackhardt F, Gräfe M, Hetzer R, Fleck E. Modulation of contractions to ergonovine and methylergonovine by nitric oxide and thromboxane A2 in the human coronary artery. J Cardiovasc Pharmacol 2000; 36:631-639.
29. The Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-678.
30. Skoog I, Gustafson D. Hypertension and related factors in the etiology of Alzheimer's disease. Ann NY Acad Sci 2002; 977:29-36.